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Objectives: to test the hypotheses that increased acute phase reactants predict elevated levels of lipoproteins and increased
plaque volume as well as echolucency of carotid plaques.
Materials and Methods: the study included 258 patients with [50% carotid artery stenosis. Acute phase reactants
(orosomucoid, C-reactive protein (CRP)) were measured in the fasting state, and ultracentrifugated lipoproteins before
and after a standardised fat load test. Echogenicity of carotid plaques was detected using high-resolution B-mode ultrasound
and computer-assisted image processing. A subgroup of 81 patients underwent carotid endarterectomy.
Results: on linear regression analysis orosomucoid levels were positively associated with fasting and postprandial levels
of all triglyceride-rich lipoproteins, and negatively associated with HDL cholesterol (p-values <0.0001); results for CRP
were less pronounced. Orosomucoid and CRP both predicted the presence of an increased carotid plaque volume on
univariate analysis (p=0.01 and p=0.02). Finally, orosomucoid was negatively associated with echolucency of carotid
plaques (p=0.05).
Conclusions: elevated levels of acute phase reactants are strongly associated with elevated levels of triglyceride-rich
lipoproteins, increased plaque volume, and borderline significantly associated with echolucency of carotid plaques. Elevated
acute phase reactants possibly predict severity of atherosclerosis, and presence of lipid-rich, rupture-prone plaques.
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Introduction be detected in the blood. In support of inflammation
being involved in atherogenesis and/or in pre-
Atherosclerotic plaques are thought to result from an cipitating myocardial infarction or stroke, base-line
excessive inflammatory-fibroproliferative response to plasma concentrations of the acute phase reactant
injury; for example, by extracellular plasma lipo- C-reactive protein appear to predict future risk of
proteins in the intima.1 The inflammatory response myocardial infarction and stroke.5
consists of attraction and adhesion of monocytes and We have previously demonstrated that increased
T-lymphocytes to the endothelium with subsequent plasma levels of triglyceride-rich lipoproteins predict
migration into the intima of the vessel wall. The echolucency of carotid plaques,6,7 which is associated
resulting activated monocytes/macrophages phago- with increased plaque lipid content7,8 and a high in-
cytose lipid turning them into foam cells. Macrophages cidence of brain infarcts on CT scans.9 It is therefore
are capable of producing cytokines and growth factors possible that high plasma levels of triglyceride-rich
and inducing smooth muscle cell proliferation, ul- lipoproteins in particular promote development of
timately increasing atherosclerotic plaque size.2–4 Cy- lipid-rich plaques with increased local inflammatory
tokine secretion is an especially important event in response, and consequently a high risk of plaque
inflammation, leading to an acute phase reactant re- rupture and hemispheric neurological events. We
sponse in the liver; acute phase reactants can easily measured the acute phase reactants high sensitive C-
reactive protein (CRP) and orosomucoid as markers
of systemic inflammation, probably indicating an on-
∗ Please address all correspondence to: M.-L. M. Grønholdt, De- going local inflammation in the plaque. CRP is a verypartment of Vascular Surgery, RK 3112, Rigshospitalet, Blegdamsvej
9, DK-2100 Copenhagen Ø, Denmark. sensitive marker of inflammation, and clinically the
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most widely used acute phase reactant.16 The 1-glyco- Basic characteristics like age, sex, height and weight
were registered. Subjects with cardiac disease wereprotein orosomucoid is used clinically as the most
sensitive acute phase reactant besides CRP.16 grouped as having angina pectoris, cardiac failure or
myocardial infarction and cardiovascular risk factorsThis study tested three hypotheses: (1) increased
plasma levels of lipoproteins are associated with in- were noted: family history of myocardial infarction or
stroke (first degree relatives who before the age of 60creased levels of acute phase reactants, (2) increased
levels of acute phase reactants predict increased carotid years experienced a myocardial infarction or stroke),
hypertension (current or previous use of anti-plaque size (measured as volume), and (3) increased
levels of acute phase reactants predict echolucency of hypertensive drugs and/or blood pressure >=160/
95), diabetes mellitus (taking oral hypoglycaemiccarotid plaques.
agents, diet or insulin), and smoking habits (non-
smoker, past-smoker >10 years ago, or current
smoker).6 The study was approved by the medical
Methods ethics committee for Copenhagen and Frederiksberg
counties (# KF 01-062/94), and all patients gave in-
Subjects formed consent.
The study included 258 patients (163 men and 95
women, median age 65 years). These patients were
from a consecutively enrolled sample of 352 patients Acute phase reactants
having a degree of carotid stenosis of 50% or greater
on the symptomatic or most stenotic side being re- Levels of high sensitive CRP and orosomucoid (acid
ferred for carotid ultrasound examination at Rigs- 1-glycoprotein) were measured by conventional neph-
hospitalet in Copenhagen from 1994 through 1996. elometry (Behring Diagnostica), where the assays were
Exclusion criteria reducing the number of carotid sten- modified to be maximally sensitive within the ref-
osis patients from 352 to 258 were: excessive alcohol erence ranges for the two assays: CRP <5 mg/l and
intake (n=3), serious liver disease (n=1), cancer (n= orosomucoid 40–130 mg/dl, respectively. Plasma
2), systemic inflammatory disease (n=0), lipid-low- samples were kept at −80 °C from sampling until
ering medication (n=35), or missing the blood sample measurement in all patients and analysed sim-
for acute phase reactant measurement (n=53). Eighty- ultaneously at the end of the experiment, using only
one of the 258 included patients underwent carotid one calibration. Precision as evaluated by coefficient
endarterectomy. of variation for CRP measurements at the levels of 29
Included patients were either asymptomatic (n= and 2 mg/l (high and low levels) were 3% and 4% (n=
35 (14%)) or had experienced minor strokes (n=117 20). Likewise, coefficient of variation for orosomucoid
(45%)), transient ischaemic attack (n=78 (30%)), or measurements at the levels of 83 and 8 mg/dl (high
amaurosis fugax (n=28 (11%)). One or more CT scans and low levels) were 3% and 4% (n=20). Finally,
were performed in all stroke patients to exclude haem- accuracy was monitored via a Scandinavian monthly
orrhage as the cause of neurological symptoms. Be- external quality control program (Labquality, Helsinki,
cause all participants had [50% carotid stenosis, Finland): an unknown sample measured 20 mg/l and
possibly neurological symptoms in most patients were 96 mg/dl for CRP and orosomucoid in our assays
referable to this large vessel atherothrombotic disease. while the average levels of other Scandinavian hospital
Nevertheless, cardiac reasons for the neurological laboratories were 20 mg/l (n=268) and 94 mg/dl (n=
symptoms cannot be fully excluded, despite warfarin 36), respectively.
treatment of patients with atrial fibrillation and lack
of mural thrombus on echocardiography in patients
with bilateral neurological symptoms or atrial fib-
rillation. Fat tolerance test
We measured acute phase reactants, CRP and oro-
somucoid in all patients in the fasting state, im- Two hundred and six (58 operated and 148 not-op-
erated) consecutive enrolled patients performed a fatmediately before endarterectomy and at least 3 months
after episodes of major neurological symptoms and load test. The remaining 52 patients were either not
willing to perform this fat load test (n=22) or joinedmyocardial infarction. Patients willing to perform a
fat tolerance test (n=206) did so either 3 months after the study after this particular test had to be stopped
due to lack of manpower (n=30).inclusion or 3 months after carotid endarterectomy.
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After a 12-hour overnight fast, patients were given images were reprocessed by the same ultra-
sonographer (MLMG) to obtain a second set of greya fatty meal consisting of 1 g dairy cream fat per
kilogram body weight. Plasma lipids and lipoproteins scale values.7
were measured before and at hourly intervals for 4 h
after the fatty meal, as described previously.6 Briefly,
very low density lipoprotein (VLDL; d<1.006 g/ml),
Histological examinationintermediate density lipoprotein (IDL; 1.006 g/
ml<d<1.019 g/ml), low density lipoprotein (LDL;
During endarterectomy carotid artery plaques were1.019 g/ml<d<1.063 g/ml) and high density lipo-
removed in one piece and cut open in the verticalprotein (HDL; d>1.063 g/ml) were isolated by ultra-
direction. After cutting the specimen transversely intocentrifugation. Cholesterol and triglycerides in plasma
3 mm thick blocks (four to 14 per patient), 4 m sectionsand lipoprotein fractions were measured with en-
were cut from the individually labelled blocks andzymatic assays (CHOD-PAP and GPO-PAP, Boehringer
stained with haematoxylin and eosin, Van Gieson’sMannheim, Mannheim, Germany). The magnitude of
stain for connective tissue, and Verhoeff’s stain forpostprandial triglyceridaemia and cholesterolaemia
elastin. Plaque constituents (lipid, haemorrhage, cal-was calculated as the area under the plasma choles-
cification, thrombus, and fibrous tissue) in all sectionsterol (AUCC, AUCC-C 0h) and triglyceride (AUCTG,
were measured morphometrically by a single ex-AUCTG-TG 0h) curves 0–4 h after a fatty meal.6 Re-
perienced pathologist, using a Leitz Texture Analysingproducibility of the lipoprotein measurement during
System (TAS, Cambridge, U.K.). The total volume ofa fat tolerance test seemed to be as good as those for
each constituent in the removed plaque was calculatedfasting levels.10
as the sum of the area of the individual constituent in
all blocks multiplied by the mean distance in mm
between each section. The pathologist was unaware
of results from acute phase reactant measurements,
Ultrasound examination fat tolerance test, and ultrasound examination. Co-
efficient of variations for repeated measurements of
Using an Apogee Interspec 400 scanner and a plaque lipid and fibrous tissue content (n=10) were
5–10 MHz linear array transducer, the B-mode and 4% and 2%, respectively.7
corresponding colour Doppler images of the carotid
artery plaques on the symptomatic or most stenotic
side (for asymptomatic patients) were recorded on a
SVHS video and later digitised off-line on a PC with Statistical analysis
a Targa 2000-E framegrabber (Truevision Inc., IN,
U.S.A.). The B-mode images were then processed with Student’s t-test (to compare continuous variables be-
tween two groups), analysis of variance (ANOVA) (tothe software program Image-Pro Plus version 1.2.01
(Media Cybernetics, MD, U.S.A.): the carotid artery compare continuous variables between more than two
groups), 2-test (to compare proportions betweenplaque was outlined and the grey scale value of each
pixel in the region (0–255; 0=black and 255=white) groups), unifactorial linear regression (to correlate two
continuous variables), and analysis of covariance (AN-was used to generate a median grey scale value.7 In
the case of acoustic shadowing from a plaque, the COVA; forced entry or forward stepwise method, to
correlate several continuos or categorical variables)outline did not include this shadow region. The degree
of stenosis was determined by routine Doppler criteria were performed with the Statistica program.12 The test
used is described in every setting in the Results. Theas <50%, 50–79%, 80–99%, or occlusion. A systolic
velocity >120 cm/s equals a 50% stenosis, and forced entry ANCOVA model allowed for age, gender,
body mass index, smoking habits, diabetes mellitus,>135 cm/s diastolic velocity equals a degree of stenosis
exceeding 80%, validated by angiography as the gold- aspirin, and antihypertensive drugs (thiazide-diuretics
and betablockers). Covariates entered in the forwardstandard.11 Ultrasound examinations and computer
processing of images were all performed by a single stepwise ANCOVA are listed in Results. To approach
normal distribution, medians of grey scale values,experienced ultrasonographer (MLMG), who were un-
aware of the results from acute phase reactant meas- plaque volumes, lipoprotein(a), triglycerides in
plasma, IDL, and VLDL, cholesterol in IDL and VLDL,urements, fat tolerance test, and histological
examination. The coefficient of variation for grey scale as well as AUCTG and AUCTG-TG 0h were all transformed
logarithmically (ln) before statistical tests.measurements was 6% when 58 consecutively chosen
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Table 1. Acute phase reactants and basic characteristics of 258 Table 2. Lipids and lipoproteins in 206 patients with carotid artery
plaques.patients with carotid artery plaques.
Fasting Postprandial values 4 hAcute phase reactants
CRP (mg/l) 6.4±0.5 values after a fatty meal
Orosomucoid (mg/dl) 110±2
Fasting valuesCardiovascular risk factors Lp(a) (mg/l) 480Age (years) 64±1 Cholesterol Plasma 6.49 6.48Males (%) 63 (mmol/l) HDL 1.47 1.42BMI (kg/m2) 25±0.2 LDL 3.77 3.66Hypertension (%) 48 IDL 0.50 0.51Diabetes (%) 11 VLDL 0.74 0.89Family history (%) 32 Triglycerides Plasma 1.81 3.10
(mmol/l) HDL 0.26 0.32Ultrasound measures
Carotid stenosis 50–79% (%) 56 LDL 0.27 0.27
IDL 0.13 0.14Carotid stenosis 80–99% (%) 44
VLDL 1.24 2.36Smoking habits
Current smoker (%) 55 Area under the curve 0–4 h after a fatty meal (mmol/L)
AUCTG 2.41Past smoker (%) 26
AUCTG-TG 0h 0.59Neurological symptoms AUCC 6.41Amaurosis fugax (%) 11 AUCC-C 0h −0.07TIA (%) 30
Stroke (%) 45 Values are means. Lp(a), lipoprotein (a). HDL, high density lipo-
proteins. LDL, low density lipoproteins. IDL, intermediate densityCardiac disease
MI (%) 13 lipoproteins. VLDL, very low density lipoproteins. CR, chylomicron
remnants. TG, triglycerides. TG 0 h, fasting triglycerides. C, cho-Angina pectoris (%) 8
Cardiac failure (%) 5 lesterol. C, 0 h, fasting cholesterol. AUC, area under the curve.
Medication
Aspirin (%) 69
Warfarin (%) 34 Acute phase reactants and plasma lipoproteins
Betablockers (%) 7
Thiazide-diuretics (%) 16
Using unifactorial linear regression and analysis of
Values for CRP, orosomucoid, age, and body mass index (BMI) are covariance allowing for potential confounders, we
mean±SEM. MI, myocardial infarction more than 3 months ago. found highly significant positive associations betweenTIA, transient ischaemic attack. Family history, first degree relative
plasma levels of orosomucoid and fasting as well asbefore age 60 experienced an MI or stroke.
postprandial plasma levels of triglyceride-rich lipo-
proteins, measured as plasma triglycerides, IDLResults
triglycerides, CR/VLDL triglycerides, CR/VLDL cho-
lesterol, or the area under the plasma triglycerideLevels of acute phase reactants, cardiovascular risk
factors, degree of carotid stenosis, previous disease curve 0–4 h after a fatty meal (Tables 3 and 4). Plasma
cholesterol and the area under the plasma cholesteroland use of medications are shown in Table 1 and levels
of lipids and lipoproteins in Table 2. Although there curve were also directly related to levels of oro-
somucoid, mainly due to a strong association withwas a tendency toward higher levels of acute phase
reactants and lipoproteins in symptomatic patients, VLDL cholesterol, while IDL cholesterol and LDL
cholesterol were less strongly associated with oro-these patients did not have significantly different levels
compared with asymptomatic patients (t-test: CRP: 6.9 somucoid levels.
CRP levels were also associated positively with fast-versus 4.5 mg/l, p-value 0.07 and orosomucoid: 108
versus 106 mg/dl, p-value 0.77). Because there was no ing and postprandial levels of plasma triglycerides,
LDL triglycerides, and CR/VLDL triglycerides, as wellsignificant difference, we included all 258 patients in
this study. as with the area under the plasma triglyceride curve;
however, these associations were less pronounced thanLevels of CRP and orosomucoid were highly cor-
related (r=0.62, p<0.000001). CRP levels, but not oro- for orosomucoid levels and some of these associations
disappeared on multifactorial analysis (Tables 3 and 4).somucoid levels, were higher in men than in women
(t-test: CRP: 7.2 versus 5.1 mg/l, p=0.002 and oro- Fasting and postprandial HDL cholesterol were
strongly negatively associated with both orosomucoidsomucoid: 111 versus 108 mg/dl, p=0.48). Finally, BMI
correlated positively with both CRP and orosomucoid and CRP levels on both unifactorial and multifactorial
analysis (Tables 3 and 4). Finally, orosomucoid levelslevels (r=0.26, p=0.0002 and r=0.20, p=0.005, re-
spectively). The other characteristics shown in Table were directly associated with levels of LDL tri-
glycerides and lipoprotein (a).1 did not correlate with CRP or orosomucoid levels.
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Table 3. Unifactorial linear regression analysis of levels of C-reactive protein and orosomucoid versus levels of lipids and lipoproteins
before, during, and after a fat tolerance test in 206 patients with carotid stenosis.
Fasting values Postprandial values 4 h after a fatty meal
C-reactive protein Orosomucoid C-reactive protein Orosomucoid
r p-value r p-value r p-value r p-value
Lp(a) 0.05 0.54 0.18 0.01
Cholesterol Plasma 0.02 0.74 0.31 0.00001 0.02 0.80 0.30 0.00001
HDL −0.34 0.000001 −0.28 0.0001 −0.32 0.000003 −0.28 0.00005
LDL 0.09 0.20 0.19 0.01 0.09 0.18 0.19 0.01
IDL −0.01 0.89 0.15 0.04 0.00 0.96 0.17 0.02
VLDL 0.12 0.09 0.36 0.000000 0.11 0.12 0.33 0.000001
Triglycerides Plasma 0.21 0.003 0.44 0.000000 0.21 0.002 0.37 0.000000
HDL −0.19 0.01 0.01 0.88 −0.07 0.34 0.04 0.58
LDL 0.23 0.001 0.32 0.000002 0.14 0.04 0.24 0.0004
IDL 0.10 0.16 0.27 0.0001 0.13 0.06 0.25 0.0003
VLDL 0.21 0.003 0.38 0.000000 0.20 0.004 0.32 0.000003
Area under the curve 0–4 h after a fatty meal
AUCTG 0.19 0.007 0.41 0.000000
AUCTG-TG 0h 0.12 0.08 0.18 0.01
AUCC 0.01 0.87 0.31 0.00001
AUCC-C 0h −0.02 0.77 −0.04 0.53
Table 4. Analysis of covariance of levels of C-reactive protein and orosomucoid as predictors of lipids and lipoproteins before, during,
and after a fat tolerance test in 194 patients with carotid stenosis.
Fasting values Postprandial values 4 h after a fatty meal
C-reactive protein Orosomucoid C-reactive protein Orosomucoid
r p-value r p-value r p-value r p-value
Lp(a) 0.08 0.28 0.18 0.01
Cholesterol Plasma 0.03 0.70 0.30 0.00002 0.008 0.91 0.29 0.0001
HDL −0.25 0.001 −0.25 0.001 −0.25 0.001 −0.29 0.0001
LDL 0.12 0.08 0.21 0.003 0.11 0.11 0.20 0.004
IDL −0.06 0.41 0.11 0.11 −0.02 0.76 0.14 0.04
VLDL 0.02 0.81 0.31 0.00002 −0.01 0.86 0.28 0.0001
Triglycerides Plasma 0.14 0.05 0.44 0.000000 0.12 0.08 0.36 0.000001
HDL −0.16 0.03 0.02 0.98 −0.08 0.23 0.03 0.69
LDL 0.24 0.001 0.34 0.000001 0.15 0.04 0.23 0.001
IDL 0.11 0.11 0.24 0.001 0.13 0.06 0.25 0.0005
VLDL 0.14 0.06 0.38 0.000000 0.11 0.13 0.32 0.00001
Area under the curve 0–4 h after a fatty meal
AUCTG 0.08 0.11 0.40 0.000000
AUCTG-TG 0h −0.02 0.64 0.14 0.06
AUCC 0.03 0.71 0.29 0.00007
AUCC-C 0h 0.05 0.42 −0.10 0.17
Models allowed for age, gender, body mass index, smoking habits, diabetes mellitus, aspirin, and antihypertensive drugs (thiazide-
diuretics and betablockers); of the 206 patients included in the unifactorial analysis (Table 3), 12 did not have information on one or more
of these covariates. No correction for multiple comparison was performed.
A step-up analysis of covariance included lipids, The results shown in Tables 3, 4, and 5 were only
modified slightly when the analysis additionally al-lipoproteins, age, and gender as predictors of acute
phase reactants (Table 5). In this analysis fasting HDL lowed for the presence of previous neurological symp-
toms, time-interval between the latest focalcholesterol, fasting LDL triglycerides, and gender were
independent predictors of CRP levels (Table 5). Fasting neurological symptom, blood sampling for acute phase
reactant measurement, and for presence of anginaplasma triglycerides, fasting plasma cholesterol, fast-
ing HDL cholesterol, and lipoprotein (a) were in- pectoris/cardiac failure or previous myocardial in-
farction (data not shown).dependent predictors of orosomucoid levels (Table 5).
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Table 5. Ranking by analysis of covariance of independent pre- Discussion
dictors of levels of C-reactive protein and orosomucoid.
Dependent variable Rank Multiple R2 R2 change p-value We have demonstrated that elevated levels of acute
Independent variables phase reactants are strongly associated with elevated
levels of triglyceride-rich lipoproteins, increasedC-reactive protein
Fasting HDL 1 0.11 0.11 0.000001 plaque volume and border-line significantly associated
cholesterol with echolucency of carotid plaques. This suggests
Fasting LDL 2 0.14 0.03 0.01 that elevated acute phase reactants possibly predict thetriglycerides
Gender 3 0.16 0.02 0.02 severity of atherosclerosis and possibly the presence of
lipid-rich, rupture-prone plaques.
Orosomucoid
Fasting plasma 1 0.17 0.17 0.000000
triglycerides
Fasting plasma 2 0.22 0.05 0.001
cholesterol Acute phase reactants and plasma lipoproteinsFasting HDL 3 0.24 0.02 0.03
cholesterol
Lipoprotein (a) 4 0.26 0.02 0.04 The most important observation in the present study
is the strong positive association between fasting andStep-up analysis of covariance included the significant (pΖ0.05)
postprandial plasma levels of triglyceride-rich lipo-lipid and lipoprotein predictors of C-reactive protein or orosomucoid
on unifactorial analysis as shown in Table 3, as well as age and proteins and acute phase reactants (or inverse relation
gender. Only predictors that were independently statistically sig- to HDL levels); multifactorial analysis showed that thisnificant were ranked.
association was independent of other well-established
cardiovascular risk factors (listed under Table 4). It was
furthermore independent of the time-interval betweenAcute phase reactants and carotid plaque volume
blood sampling and of previous cardiac or focal neuro-
logical symptoms. In accordance with this finding,On unifactorial linear regression analysis, total plaque
previous studies have observed positive associationsvolume and total plaque fibrous tissue were directly
between fasting plasma triglycerides and levels ofrelated to orosomucoid and CRP levels (Table 6); only
cytokines,17,18 the molecular mediates between in-orosomucoid levels were directly related to total
flammation and elevated levels of acute phase re-plaque lipid. When the analyses allowed for the time-
actants. Furthermore, CRP and fibrinogen levels haveinterval between the latest focal neurological symptom
been related to plasma triglycerides.19–22and measurement of acute phase reactants (bifactorial
Our observations could be interpreted to suggestanalysis, Table 6), the results were similar. On analysis
either (1) that inflammatory and infectious diseaseof covariance allowing for other potential confounders,
cause hypertriglyceridaemia/low HDL cholesterol ororosomucoid levels still predicted total plaque volume
(2) that hypertriglyceridaemia/low HDL cholesteroland total plaque fibrous tissue (multifactorial analysis,
leads to inflammation. In favour of the first possibility,Table 6). Acute phase reactants were not associated
chronic infections lead to higher levels of acute phasewith the degree of carotid artery stenosis (over and
reactants that could cause elevated triglycerides and/under 80% stenosis: CRP 6.6 versus 6.3 mg/l, p-value
or reduction in HDL cholesterol:19–22 inflammatory sig-0.91 and orosomucoid 113 versus 107 mg/dl, p-value
nals alter lipoprotein metabolism. Observations in fa-0.13).
vour of the second possibility are (1) that severely
elevated levels of triglyceride-rich lipoproteins may
cause eruptive xanthomas, inflammatory lipid-rich
Acute phase reactants and carotid plaque echogenicity lesions in the skin, as well as pancreatitis,23 (2) that
elevated plasma triglycerides are independent pre-
Grey scale level of carotid atherosclerotic plaques (grey dictors of atherosclerosis24,25 and coronary heart dis-
scale median; continuous scale from 0 to 255) was ease.26
negatively associated with orosomucoid levels on uni-
factorial linear regression; however, when the time-
interval from the latest focal neurological symptom
(bifactorial analysis) or other potential confounders Acute phase reactants and carotid plaque volume
(multifactorial analysis) were allowed for, this as-
sociation became insignificant (Table 6). CRP levels Our results also indicate that the larger the plaque
volume (in total, lipid and fibrous tissue), the greaterwere not associated with grey scale level.
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Table 6. Unifactorial, bifactorial, and multifactorial analysis of levels of C-reactive protein and orosomucoid as predictors of carotid
artery plaque ultrasonic echogenicity (grey scale level), total plaque volume, total plaque lipid, and total plaque fibrous tissue.
Grey scale median Total plaque volume Total plaque lipid Total plaque fibrous tissue
r p-value r p-value r p-value r p-value
Unifactorial analysis (n=235) (n=81) (n=81) (n=81)
C-reactive protein −0.02 0.71 0.26 0.02 0.16 0.14 0.34 0.002
Orosomucoid −0.13 0.05 0.29 0.01 0.24 0.03 0.32 0.003
Bifactorial analysis (n=233) (n=81) (n=81) (n=81)
C-reactive protein −0.01 0.85 0.27 0.02 0.16 0.16 0.34 0.002
Orosomucoid −0.10 0.10 0.30 0.01 0.24 0.03 0.32 0.004
Multifactorial analysis (n=213) (n=74) (n=74) (n=74)
C-reactive protein 0.03 0.69 0.14 0.30 0.03 0.77 0.21 0.05
Orosomucoid −0.12 0.09 0.31 0.02 0.18 0.15 0.26 0.01
Bifactorial linear regression analysis allowed for the time-interval between the latest focal neurological symptom and blood sampling for
acute phase reactant measurement. Multifactorial models (analysis of covariance) allowed for age, gender, BMI, smoking habits, diabetes
mellitus, aspirin, and antihypertensive drugs (thiazide-diuretics and betablockers). Absolute levels of grey scale median, total plaque
volume, total plaque lipid, and total plaque fibrous tissue were (mean±SEM) 52±1, 726 mm3±39 mm3, 235 mm3±25 mm3,
408 mm3±21 mm3, respectively.
the inflammatory response measured as increased of echolucent, lipid-rich plaques, plaques that are sup-
posed to be particularly vulnerable to rupture in cor-levels of acute phase reactants. This is in accordance
with previous observations that increased carotid in- onary arteries34 and to causing myocardial infarction.
Atherogenesis in coronary arteries probably resemblestima-media thickness as measured by ultrasound cor-
relate with orosomucoid27 and fibrinogen levels.28,29 that in carotid arteries, leading to the assumption
that rupture of carotid plaques results in hemisphericFurthermore, the severity of coronary atherosclerosis
as determined by coronary angiography correlates neurological events.
positively with orosomucoid30 and CRP31 levels. Since
inflammation appears to be important in athero-
genesis,1 it could be speculated that as more athero-
sclerosis present in the body as a whole, higher levels
Limitationsof acute phase reactants will occur in the plasma. On
the other hand, increased acute phase reactants may
Acute illness affects levels of acute phase reactantsindicate an activated state in atherosclerosis.
and therefore is a likely confounder in this type of
study; however, the association between elevated
levels of acute phase reactants and both increased
levels of triglyceride-rich lipoproteins and increasedAcute phase reactants and echogenicity
carotid plaque volume remained significant after al-
lowances for the time-interval between blood samplingWe found that echolucency of carotid artery plaques
had a borderline significance when related to increased and the latest focal neurological symptom. Potential
patient selection bias exists because we only includedorosomucoid levels in plasma. In a previous study,
plaque echolucency was directly related to relative patients with carotid atherosclerosis, and mostly
patients with previous focal neurological symptomsplaque lipid content, and inversely related to relative
plaque fibrous tissue content.7 Fibrous plaques dom- (n=223 or 86%). In addition, there was selection of
patients with a greater degree of stenosis in the en-inated by smooth muscle cells are generally stable,
while lipid-rich plaques dominated by inflammatory darterectomy subgroup.
In conclusion, our data demonstrate that elevatedcells like macrophages and T-lymphocytes are un-
stable, increasing the likelihood of clinical events.32 In levels of acute phase reactants are strongly associated
with elevated levels of triglyceride-rich lipoproteinsaccordance with this, echolucency of carotid artery
plaques has been found to be related to an increased and low HDL levels, associated with increased carotid
plaque volume, and borderline significantly associatednumbers of infarcts on computed tomography scans9
and an increased risk of hemispheric neurological with echolucency of carotid artery plaques. One could
therefore speculate that elevated acute phase reactantssymptoms.33 Therefore, although only having a bor-
derline significance, one could speculate whether el- may predict severity of atherosclerosis, and possibly
the presence of lipid-rich, rupture-prone plaques.evated levels of orosomucoid may predict the presence
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